Introduction
============

The 'hygiene hypothesis' suggests that increased exposure to microbial infections in early childhood reduces the risk of T-helper cell 2 (Th2) predominant atopic conditions.^[@bib1; @bib2; @bib3]^ Previous studies showed that, in united Germany, children from West Germany had an increased prevalence of atopic conditions and atopic sensitisation compared with those from East Germany.^[@bib4],[@bib5]^ After reunification the prevalence of atopic conditions among children from West Germany increased, but the condition of those who spent early childhood in East Germany remained unchanged. These results suggest that environmental factors during early childhood might provide protection from atopic conditions.^[@bib6]^ These findings were also observed in other parts of the world.^[@bib7]^ Different lifestyles and environment during early childhood might therefore influence the subsequent risk of atopic conditions. However, few studies have been conducted to test the hygiene hypothesis using a natural experiment of African immigrants to a westernised country such as the USA. In the early 1990s a large number of Somali immigrants settled in the USA, including Olmsted County, Minnesota. The immigration of Somali refugees allowed us to conduct the aforementioned natural experiment by assessing the prevalence of atopic conditions among this population.

Our recent study showed that Caucasian children with asthma had suboptimal immune responses to measles, mumps, and rubella (MMR) vaccine viruses.^[@bib8]^ At present it is unknown whether or not Somali immigrants with asthma have similar immunological characteristics to those observed in their Caucasian counterparts. To address this question, we conducted a cross-sectional retrospective cohort study to assess the prevalence of asthma, allergic rhinitis, and atopic dermatitis among Somali immigrants and its relation to MMR vaccine virus-specific immunoglobulin G (IgG) levels.

Methods
=======

Study design and setting
------------------------

The study was designed as a retrospective cohort study with a cross-sectional study component. According to the 2000 census, the population of Olmsted County, Minnesota was 124,277 (90.3% white compared with 89.4% in the entire state of Minnesota and 75.1% in the USA). The characteristics of Olmsted County populations are similar to those of the US Caucasian population except that a higher proportion of the working population is employed in the healthcare industry. Medical care in Olmsted County is virtually self-contained within the community. All inpatient and outpatient data have been indexed in an automated form since 1935 under the Rochester Epidemiology Project.^[@bib9],[@bib10]^ This study protocol was approved by Institutional Review Boards at Mayo Clinic and Olmsted Medical Center.

Study subjects
--------------

The subjects were a convenience sample of 89 Somali immigrants who participated in a previous MMR vaccine study; the details of the subjects have been reported previously.^[@bib11],[@bib12]^ Briefly, the original study cohort consisted of otherwise healthy individuals aged \<30 years during the original vaccine study who had received a single dose of MMR vaccine after immigrating to the USA. Of the 89 original cohort subjects, 18 were not matched with clinic numbers from the two medical centers used in this study, eight subjects denied authorisation of medical record review for research, and one subject was born in Olmsted County and was therefore not considered to be a Somali immigrant. As a result, 27 subjects were excluded from the present study. No medical records from Somalia were available for these participants so the asthma and atopic condition status as well as immunisation record was unknown. Informed consent and/or assent was obtained from the subject and/or guardians.

Ascertainment of asthma and other atopic conditions
---------------------------------------------------

We conducted a comprehensive medical record review for all subjects to collect pertinent data. Asthma status was ascertained by applying predetermined criteria for asthma, which has been widely used in studies for asthma epidemiology.^[@bib8],[@bib13; @bib14; @bib15; @bib16; @bib17; @bib18; @bib19]^ The criteria for asthma are shown in [Box 1](#box1){ref-type="boxed-text"}. Ascertainment of atopic dermatitis or eczema and allergic rhinitis or hay fever was based on a physician diagnosis documented in the medical records. We also collected pertinent data to address the study aims such as demographic and clinical data.

MMR vaccine virus-specific IgG levels
-------------------------------------

Measles, mumps, and rubella-specific circulating IgG levels were measured using ELISA. The details of the assay methods have been previously described.^[@bib11]^ The median coefficient of variation among duplicate sample testing in our laboratory was 6.6%.

Statistical analysis
--------------------

We compared the prevalence of asthma, allergic rhinitis or hay fever, and atopic dermatitis or eczema between the study subjects with and without atopic conditions using a χ^2^ test. We subsequently compared MMR vaccine-specific IgG levels between subjects with and without asthma using ANCOVA to adjust the duration between the date of MMR vaccination and the time of measuring antibody levels. As a secondary analysis, we also assessed MMR vaccine virus-specific IgG levels between those with and without atopic conditions other than asthma.

Results
=======

Study subjects
--------------

The characteristics of the study subjects are summarised in [Table 1](#tbl1){ref-type="table"}. Of the 62 eligible subjects, 29 (47%) were male; the mean±SD age was 9.5±4.2 years for children and 22 years for adults, and 48 (77%) were under the age of 18 at the time of enrollment in the original study. The mean±SD age of the study subjects at the time of migration from Somalia to the USA was 8.6±4.4 years.

Prevalence of asthma and other atopic conditions
------------------------------------------------

Of the 62 study subjects, 10 (16%) had asthma and 22 (35%) had other atopic conditions. All the subjects with asthma were children, whereas 18 children and four adults had other atopic conditions. The results are summarised in [Table 1](#tbl1){ref-type="table"}. Five subjects (8%) were diagnosed with atopic dermatitis or eczema and 17 (27%) were diagnosed with hay fever, allergic rhinitis, or allergic conjunctivitis.

MMR vaccine virus-specific IgG levels
-------------------------------------

The results are summarised in [Table 2](#tbl2){ref-type="table"}. The mumps virus IgG level in subjects with asthma was lower than in those without asthma, adjusting for the duration between MMR vaccination and blood draw for measurement of antibody. However, there were no differences in measles and rubella vaccine-specific IgG levels between subjects with and without asthma. Mumps virus-specific IgG antibody levels were slightly lower in individuals with other atopic conditions than in those without other atopic conditions (mean±SE 2.68±0.26 vs. 3.02±0.15), but the difference did not reach statistical significance (p=0.216). There were no differences in measles vaccine-specific IgG levels and rubella vaccine-specific IgG levels between overall subjects with and without other atopic conditions (p=0.59 and p=0.31, respectively).

Discussion
==========

Main findings
-------------

We hypothesised that the Somali immigrants would have a lower prevalence rate of asthma and other atopic conditions than their Caucasian counterparts in our community due to increased microbial infections during early childhood since they spent their early childhood in Somalia (or other parts of Africa), given their mean age at the time of migration (8.6±4.4 years). However, Somali immigrants in our study, primarily children (77%) with a mean age of 9 years, had a similar prevalence of asthma (16%) to that in our community (12.9--17.6%)^[@bib20]^ and that of the USA (4--17%) despite a relatively shorter duration of follow-up than Caucasian children born in the community.^[@bib21],[@bib22]^ Similarly, the Somali immigrants had comparable prevalence rates of atopic dermatitis (8%) and allergic rhinitis (27%) to those in the USA (10--19% atopic dermatitis and 26--33% allergic rhinitis).^[@bib23; @bib24; @bib25]^ In addition, we found that Somali immigrants with asthma had significantly lower anti-mumps virus-specific IgG levels than those without asthma. Therefore, in our study, increased exposure to microbial organisms during early childhood in the Somali immigrants (as supported by the high prevalence of latent tuberculosis) may not reduce the risk of atopic conditions based on this natural experiment, and the results are counter to the hygiene hypothesis.

Strengths and limitations of this study
---------------------------------------

The main strength of our study was the epidemiological advantage of our study setting, which includes a self-contained healthcare environment, availability of the entire medical records for research, and a relatively large population of Somali refugees. Another strength was the use of criteria-based asthma ascertainment instead of self-report or a physician diagnosis alone. The data abstractor was blind to laboratory data (antibody levels) to avoid performance bias. Our study has inherent limitations as a retrospective study. We did not have data on previous immunisation records or potential past exposure to wild MMR viruses, nor did we have data on atopic sensitisation status and we did not assess other immunological parameters such as cell-mediated immunity. Our study was based on a small sample size which may have led to a type II statistical error. Because of the natural experiment, our study was based on Somali immigrants and the generalisability of our study findings might be limited to other populations or settings.

Interpretation of findings in relation to previously published work
-------------------------------------------------------------------

The literature has been inconsistent in supporting^[@bib26],[@bib27]^ and disputing^[@bib28],[@bib29]^ the hygiene hypothesis. Recent studies suggest that the effect of microbial infections during early childhood on the risk of atopic conditions might be mediated through a gene-environmental interaction^[@bib30]^ and epigenetic influences.^[@bib31]^ Our study could not address this aspect, but perhaps it would be interesting and important to assess the gene-environment interaction in this unique population group.

Studies have shown that mumps virus antibodies wane faster than those against the measles or rubella vaccine virus.^[@bib32],[@bib33]^ Higher antibody levels against measles vaccine virus were seen than against mumps vaccine.^[@bib34]^ The rationale for these differential immune responses among different vaccine viruses is unknown, and it is difficult to address given the small sample size and the potential of unknown exposure to previous MMR vaccines and wild MMR viruses. We postulate that the more rapid waning of humoral immunity against mumps virus than against measles and rubella viruses may show the systemic effect of asthma on humoral immunity earlier than its impact on humoral immunity against measles and rubella vaccine viruses. In support of this finding, we recently demonstrated that subjects with asthma had suboptimal cell-mediated immune response to measles, mumps, and rubella vaccine viruses after MMR vaccination^[@bib8]^ and a more rapid waning of anti-measles virus-specific IgG levels than children without asthma.^[@bib35]^ Noseworthy *et al.* conducted a cross-sectional study that assessed measles and mumps IgG levels among 48 children with asthma aged 1.6--17 years who had received two doses of MMR vaccine. The results showed that seronegativity in measles and mumps vaccine responses were 50--73% and 42--90%, respectively, depending on the age of the children.^[@bib36]^ Previous studies reported that Th2 cytokines or house dust mite sensitisation reduced humoral immune responses or antibody titres.^[@bib37; @bib38; @bib39]^ Taken together, our study results may counter the hygiene hypothesis. For the previously reported inverse correlation between atopic tendency and the degree of delayed type hypersensitivity to *Mycobacterium tuberculosis*,^[@bib40]^ our study results may imply abnormal T-cell development in atopics (resulting in potentially decreased immunity against mumps vaccine virus) as suggested by Prescott *et al.*, which may still apply to Somali immigrants who may have had increased exposure to microbial infections during early childhood.^[@bib41],[@bib42]^ Further studies are needed in this area.

Implications for future research, policy and practice
-----------------------------------------------------

Our study results highlight the fact that a straightforward interpretation of the hygiene hypothesis should be made with caution, and the inverse correlation between immune responses to microbial agents and atopy tendency could be confounded by immune incompetence potentially associated with asthma. As recently suggested, the impact of asthma status or other atopic conditions on innate and humoral immune functions^[@bib43; @bib44; @bib45; @bib46]^ and susceptibility to microbial infections^[@bib47; @bib48; @bib49; @bib50; @bib51; @bib52; @bib53; @bib54]^ should be considered in understanding the relationship between microbial infection and the development of atopic diseases. Further research is needed to clarify the relationship.

Conclusions
-----------

Our study results may not support the hygiene hypothesis. The previously reported abnormal T-cell development in Caucasian children with atopy can be considered even in Somali immigrants who may have had increased exposure to microbial infections during early childhood. Assessment of the cell-mediated immune response to the MMR vaccine viruses in this population with and without asthma needs to be considered in a future study.
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###### Demographic and clinical characteristics of study subjects
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###### Comparison of measles, mumps and rubella (MMR) virus IgG antibody levels in Somali subjects with and without asthma
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###### Definition of asthma

Patients were considered to have *definite* asthma if a physician had made a diagnosis of asthma and/or if each of the following three conditions was present, and they were considered to have *probable* asthma if only the first two conditions were present: History of cough, dyspnoea, and/or wheezing, OR history of cough and/or dyspnoea plus wheezing on examination,Substantial variability in symptoms from time to time or periods of weeks or more when symptoms were absent, andTwo or more of the following: Sleep disturbance by nocturnal cough and wheezeNon-smoker (14 years or older)Nasal polypsBlood eosinophilia higher than 300/μLPositive wheal and flare skin tests OR elevated serum IgEHistory of hay fever or infantile eczema OR cough, dyspnoea, and wheezing regularly on exposure to an antigenPulmonary function tests showing one forced expiratory volume in one second (FEV~1~) or forced vital capacity (FVC) \<70% predicted and another with at least 20% improvement to an FEV~1~ of \>70% predicted OR methacholine challenge test showing ≤20% decrease in FEV~1~Favourable clinical response to bronchodilator
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